Hosted on MSN14d
Abbott's Lingo wins 2025 innovation award
Abbott has received an innovation award for Lingo, its first consumer biowearable over-the-counter device designed to support ...
drugdeliverybusiness12d
Abbott Diabetes spurs growth with 22.7% uptick in CGM revenue, expects more insulin pump connectivity
Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.
Everyday Health on MSN11mon
FDA Approves the First Over-the-Counter Continuous Glucose Monitor (CGM)
The FreeStyle Libre 3 CGM, the Dexcom G7’s biggest competitor ... In response to the trend, a variety of telehealth programs ...
Morningstar21d
Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe
Omnipod 5 is now available with both Abbott’s FreeStyle Libre 2 Plus and Dexcom G6 Continuous Glucose Monitoring (CGM) sensor compatibility. Indicated for individuals aged two years and older ...
VietnamPlus18d
Abbott's life-changing tech Lingo wins 2025 innovation award
Abbott has won an innovation award for Lingo, its first consumer biowearable over-the-counter device to empower people in improving overall health and wellness.